Serological study of leprosy employing ELISA with arabinogalactan ofMycobacterium smegmatisas antigen

Comparative sensitivity of six serological tests and diagnostic value of ELISA using purified antigen in hydatidosis.

Most serodiagnostic techniques have been evaluated for diagnosis of cystic hydatid disease caused by Echinococcus granulosus. Each, to varying degrees, has been shown to give false results, with considerable variation between laboratories. The comparative study was made concerning the sensitivity of the immunodiagnostic methods based on 58 sera from hydatid disease with different cyst locations...

Performance of Leishmania PFR1 recombinant antigen in serological diagnosis of asymptomatic canine leishmaniosis by ELISA

BACKGROUND Leishmania infantum is a protozoan parasite transmitted by phlebotomine sand flies that causes life-threatening disease in humans and dogs. The dog is the primary reservoir of the parasite and early diagnosis of canine leishmaniosis is crucial at the clinical and epidemiological level. The currently available serological tests for CanL diagnostic show limitations therefore the aim of...

Mycoplasma agalactiae 111-The Comparison of Different Serological Tests with M. agalactiae Antigen

Serological tests in 150 cases of leprosy.

Hansen's disease is considered to be one of the well-known infections which upset serological tests for syphilis in patients in whom there has been no past or current treponemal infection. The reason why lepers are biological false positive (B.F.P.) reactors and why this failure in the specificity of lipoidal reactions occurs remains obscure. The frequency of false positive reactions is said to...

Serological ELISA for SBV currently being evaluated.

Recent developments in the disease situation surrounding Schmallenberg virus (SBV) in northern Europe are discussed in the latest outbreak assessment from the International Disease Monitoring (IDM) team at Defra. In the assessment, which was published on 23 Apr 2012, the IDM team says that AHVLA laboratories are currently validating a serological ELISA that has become commercially available in ...